Below are the top drug delivery stocks on the NASDAQ in terms of EPS growth forecast for the next five years.
Alkermes Plc ALKS earnings per share growth forecast for the next five years is 35.00 percent. Alkermes' trailing-twelve-month gross margin is 74.70 percent.
Flamel Technologies S.A. (ADR) FLML EPS growth forecast for the next five years is 33.00 percent. Flamel Technologies' trailing-twelve-month revenue is $42.90 million.
Delcath Systems, Inc. DCTH EPS growth forecast for the next five years is 15.00 percent. Delcath Systems' trailing-twelve-month revenue is $1.40 million.
Petmed Express Inc PETS earnings per share growth forecast for the next five years is 5.00 percent. Petmed Express' PEG ratio is 3.52.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in